REMOTE-FIRST COMPANY/NEW YORK--(BUSINESS WIRE)-- #NextGenHealthcare--NextGen Healthcare's Practice Management (PM) solutions have been ranked #1 by Black Book Market Research for the 9th consecutive year. Rankings in the independent market research firm's 2026 Physician Practice Management Software (PPMS) user-satisfaction report are based on a comprehensive 9-month survey of more than 24,500 validated users across the U.S. Black Book's analysis characterizes NextGen Healthcare as a leader in innovation for ...

MCLEAN, Va., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions company dedicated to accelerating better health outcomes for government and commercial clients and the populations they serve, announced today its recognition among Modern Healthcare’s 2025 Best in Business in the Healthcare IT category. The award celebrates organizations that drive innovation, efficiency, and excellence across the healthcare industry. By acknowledging the leading innovators within the industry, ...

This story was originally published on Healthcare Dive. To receive daily news and insights, subscribe to our free daily Healthcare Dive newsletter. Dive Brief: Private equity dealmaking in healthcare surged in 2025, boosted in part by investor interest in health IT firms, according to a report published last week by Bain & Company. Healthcare deal value soared to a record-breaking $191 billion last year, surpassing earlier heights seen in 2021, the consultancy estimated using data through November. Th ...

Market Overview - The Global Referral Management Market is projected to grow at a CAGR of 15.8% from 2024 to 2031, increasing from USD 4.17 Billion in 2024 to USD 13.48 Billion by the end of the forecast period [1][3]. Key Drivers - The market is primarily driven by the growing demand for coordinated patient care, as healthcare providers seek improved communication between departments to enhance patient outcomes and operational efficiency [3]. - The swift transition towards digital healthcare solutions is significantly influencing the market, with the integration of referral management systems being crucial for continuity of care as providers adopt electronic health records (EHRs) and telehealth services [4]. - Government initiatives and regulatory support are vital for market growth, as policies promoting healthcare IT adoption and accountable care organizations (ACOs) create a favorable environment for referral management systems [5]. Market Challenges - Data security and privacy concerns pose a significant limitation, as the digitization of patient information raises fears of data breaches and unauthorized access, potentially hindering market expansion [6][7]. - High implementation and maintenance costs are substantial obstacles, particularly for smaller healthcare providers, as the financial burden can restrict the adoption of referral management systems [8]. - The complexity of integrating referral management systems with existing healthcare infrastructure presents challenges, as providers may struggle to incorporate new technologies with outdated systems, which can disrupt operations [9]. Geographical Insights - North America dominates the referral management market due to its advanced healthcare infrastructure, high digital health technology usage, and strong regulatory environment, which fosters innovation and sets industry standards [10]. Key Players - Major players in the Global Referral Management Market include Ambition, BetterUp, Boxever, Brand24, Extole, Fivestars, Greateasy, Influitive, Joolea, Kickback, Mention, NPSoftware, Outfunnel, ReferralCandy, RewardSheep, Socialbakers, Smarter Referrals, and Talkable [11].

Doximity Inc. (NYSE:DOCS) is one of the oversold stocks to buy now. On December 15, Morgan Stanley upgraded Doximity to Overweight from Equal Weight with a price target of $65, which was increased from $62. Morgan Stanley stated that Doximity’s recent stock underperformance is inconsistent with the company’s business checks and the platform’s growing user engagement. The firm suggested that both company guidance and Street estimates appear conservative, creating what they view as an attractive entry point ...

Industry Overview - Healthcare information technology (IT) is attracting significant investor interest in 2025 due to the acceleration of digital transformation in the U.S. health system, with investments aimed at enhancing telehealth access, streamlining workflows, and improving chronic disease management [1][2] - The global healthcare IT market was valued at $663 billion in 2023 and is projected to grow to $1,834.3 billion by 2030, reflecting a compound annual growth rate (CAGR) of 15.8% from 2024 to 2030, with North America holding over 40% of the market share in 2023 [3] Investment Opportunities - Investors are focusing on companies that offer scalable technology with recurring revenue models, as several healthcare IT stocks have outperformed broader indices in 2025, driven by strong fundamentals and product expansion [4] - Notable U.S.-listed stocks include Hims & Hers Health, Inc. (HIMS), Biotricity, Inc. (BTCY), and Privia Health Group, Inc. (PRVA), all of which have seen year-to-date share price gains exceeding 20% [4][10] Company Highlights Hims & Hers Health, Inc. (HIMS) - HIMS has gained 44.9% in 2025, focusing on a consumer-centric telehealth platform that offers personalized treatment plans and wellness solutions across various health domains [6] - The company reported nearly $600 million in Q3 revenues, a 49% year-over-year increase, with a subscriber base growth of about 21% to approximately 2.5 million [7] - HIMS is expanding its services and has initiated a $250 million share repurchase program, indicating confidence in long-term value creation [8] Biotricity, Inc. (BTCY) - BTCY has risen 25.9% year-to-date, focusing on remote patient monitoring solutions that support chronic disease management, particularly in cardiac care [11] - The company is recognized as one of the fastest-growing companies in the Americas, with improved gross margins and progress toward profitability [12][13] - Key metrics to monitor include recurring revenue growth and margin expansion as the company broadens its clinical applications [14] Privia Health Group, Inc. (PRVA) - PRVA has achieved a 22.9% stock growth in 2025, with Q3 revenues up 32.5% to $580.4 million and operating income increasing nearly 150% [19] - The company emphasizes value-based care and has expanded geographically through acquisitions, raising its full-year guidance [20] - Analysts maintain a strong buy view on PRVA, with sales and earnings estimates for 2026 suggesting growth of 9.7% and 142.9%, respectively [21]

Core Insights - HeartSciences Inc. has announced the commercial release of MyoVista Insights™ version 1.1, enhancing usability and clinical interpretation capabilities of ECG systems [1][2] - The platform is designed to improve workflow efficiency and expand interoperability across various ECG devices, making it a vendor and device agnostic solution [2][3] Product Features - MyoVista Insights is a cloud-native ECG management system that integrates AI ECG algorithm models from multiple partners, streamlining data management and improving workflow efficiency [2] - The updated version 1.1 provides a more intuitive platform for cardiac care, allowing clinicians to quickly interpret complex ECG data and make informed decisions [3] Market Position - Since its launch in May 2025, MyoVista Insights has received strong validation from early adopters and is currently in commercial discussions with several leading healthcare institutions [2] - The company aims to announce key customer deployments in the near term, indicating a positive market reception and potential growth opportunities [2]

Core Viewpoint - Healthcare Triangle, Inc. is acquiring Teyame AI LLC and its subsidiaries, enhancing its position in AI-powered customer and patient engagement solutions [1][2][3] Financial Overview - The total consideration for the acquisition is expected to be approximately $50 million, comprising cash, common stock, non-voting convertible preferred stock, and contingent earnout-based equity [2] - The acquisition is projected to generate about $34 million in incremental annual revenue and $4.2 million in incremental EBITDA for fiscal year 2025 [3] Strategic Importance - This acquisition marks a significant transition for Healthcare Triangle from a healthcare IT provider to a comprehensive digital health innovator, aiming to enhance financial performance and shareholder value [3] - The integration of AI-powered engagement platforms with existing healthcare technologies is expected to create an intelligent ecosystem for patients and providers [5] Technological Advancements - The acquired assets include advanced AI capabilities such as chatbot automation, multilingual patient engagement tools, and real-time analytics, which will enhance HCTI's clinical systems [8][10] - The transaction aims to leverage Agentic Generative AI to improve operational efficiency and drive innovation in healthcare services [4][10] Market Positioning - The acquisition positions Healthcare Triangle as a global leader in AI-powered customer experience solutions, targeting high-growth international markets [7]

Core Viewpoint - Nanox Imaging Ltd has announced the acquisition of VasoHealthcare IT Inc to enhance the deployment of its AI solutions in U.S. healthcare facilities, with the transaction expected to be completed within weeks [1][2]. Company Overview - Nanox is focused on transforming healthcare through affordable medical imaging technologies that leverage advanced AI and proprietary digital X-ray sources [8]. - Vaso Corporation operates in diversified sectors, including healthcare technology and medical devices, with VHC IT being a key player in healthcare information technology [10]. Acquisition Details - The acquisition will involve a total consideration of up to $800,000, which includes a $200,000 cash payment at closing and up to $600,000 in performance-based earnout payments over two years, contingent on revenue retention from existing customers [5]. - VHC IT specializes in healthcare IT implementation, providing services such as systems integration, workflow optimization, and user training, which will be integrated with Nanox's AI solutions [3][4]. Strategic Implications - The integration of VHC IT's operational infrastructure with Nanox.AI's FDA-cleared solutions is expected to accelerate the deployment and adoption of AI technologies in medical imaging, enhancing the customer experience [4][6]. - The acquisition is anticipated to support Nanox's commercial expansion in the U.S. by leveraging VHC IT's expertise and established customer relationships [4][6].

Group 1 - The article does not provide any specific content or key points related to a company or industry [1]